Advances in oral delivery of anti-cancer prodrugs-Reference-Cited by-同舟云学术

Advances in oral delivery of anti-cancer prodrugs

Published:2016-07-06 Issue:12 Volume:13 Page:1759-1775
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Jain Amit K.¹,Jain Sanyog²

Affiliation:

1. Department of Chemical Engineering, Texas Tech University, Lubbock, TX, USA

2. Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, Punjab, India

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2016.1200554

Reference180 articles.

1. Global cancer statistics, 2012

2. Engineered PLGA Nanoparticles: An Emerging Delivery Tool in Cancer Therapeutics

3. Oral cancer treatment: developments in chemotherapy and beyond

4. Oral delivery of anticancer drugs: Challenges and opportunities

5. Enhanced Oral Paclitaxel Bioavailability After Administration of Paclitaxel-Loaded Lipid Nanocapsules

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymeric Micelle-Based Nanogels as Emerging Drug Delivery Systems in Breast Cancer Treatment: Promises and Challenges;Current Drug Targets;2024-09

2. Research Advances of Lipid Nanoparticles in the Treatment of Colorectal Cancer;International Journal of Nanomedicine;2024-07

3. Carrier-free nanomedicines: Mechanisms of formation and biomedical applications;Giant;2024-06

4. A comprehensive perspective of trastuzumab-based delivery systems for breast cancer treatment;Journal of Drug Delivery Science and Technology;2024-05

5. Folic acid-conjugated curcumin-loaded bioMOF-101 for breast cancer therapy;Journal of Drug Delivery Science and Technology;2023-09